TransCelerate, a non-profit organization with a mission to identify solutions to drive efficiencies in drug development, has selected Veeva Vault SiteExchange for the Shared Investigator Platform (SIP), a platform that facilitates investigative site collaboration with multiple clinical trial sponsors.
 
The TransCelerate SIP Initiative aims to provide the industry with a centralized platform that will be interoperable with various clinical solutions, streamline communications between investigators and sponsors, and reduce redundant requests during a trial. TransCelerate chose Veeva Vault SiteExchange to help simplify document access and exchange through the SIP, and improve efficiencies, allowing clinical trial investigators, sites, and participating sponsors to have immediate and centralized access to critical documents.
 
“Veeva is a proven technology innovator and cloud leader with an excellent track record in driving greater efficiency in clinical operations,” said Janice Chang, senior vice president of global operations at TransCelerate. “The integration of Veeva Vault SiteExchange with the Shared Investigator Platform further simplifies site administrative efforts, which is core to one of our strategic priorities to improve site experience.”
 
“TransCelerate is doing exciting work to promote enhanced industry collaboration and introduce efficient ways companies can accelerate treatments to market,” said Jennifer Goldsmith, senior vice president of Veeva Vault strategy. “We’re honored to work with TransCelerate and help clinical sites and sponsors effectively manage trial documentation to get medicine to patients more quickly.”